EP Patent

EP4623897A1 — Pharmaceutical composition containing high concentration of opiranserin

Assigned to Vivozon Inc · Expires 2025-10-01 · 1y expired

What this patent protects

A pharmaceutical composition containing a high concentration of opiranserin is disclosed. More specifically, disclosed is a pharmaceutical composition comprising: opiranserin or a pharmaceutically acceptable salt thereof; a carrier selected from sodium benzoate, trisodium citrate…

USPTO Abstract

A pharmaceutical composition containing a high concentration of opiranserin is disclosed. More specifically, disclosed is a pharmaceutical composition comprising: opiranserin or a pharmaceutically acceptable salt thereof; a carrier selected from sodium benzoate, trisodium citrate, sodium salicylate and mixtures thereof; and a solvent for injection.

Drugs covered by this patent

Patent Metadata

Patent number
EP4623897A1
Jurisdiction
EP
Classification
—
Expires
2025-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Vivozon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.